News

First Trust Mortgage Income Fund Announces $0.075 Per Share Payout

First Trust Mortgage Income Fund Announces $0.075 Per Share Payout

First Trust Mortgage Income Fund Declares Monthly Distribution

First Trust Mortgage Income Fund (NYSE: FMY) has officially announced its regular monthly common share distribution of $0.075 per share. This distribution highlights the Fund's commitment to providing consistent income to its shareholders. Shareholders working within the spectrum of real estate investments can look forward to this expected payment, which plays a significant role in sustaining their investment strategies.

Understanding the Distribution Rates

The distribution, payable to shareholders of record, reflects a calculated approach to income generation. Based on the Fund's most recent net asset value (NAV) dated January 17, 2025, which was reported at $12.51, the distribution rate stands at an appealing 7.19%. Alternatively, if we consider the closing market price of $11.90 during the same period, the distribution rate slightly adjusts to 7.56%. Such metrics provide investors with clear insights into the Fund's performance and strategy.

Possible Sources of Distribution

This distribution could derive from various sources, including net investment income, net short-term realized capital gains, or return on capital. After the conclusion of the calendar year, details regarding the tax status of these distributions will be compiled and shared via Form 1099-DIV. These clarifications are crucial for investors to understand how their returns may be taxed, especially in nuanced investment environments.

Investment Strategies and Objectives

The Fund operates as a diversified, closed-end management investment company, predominantly focusing on yielding a high level of current income. In addition to providing liquidity, the Fund aims to preserve capital—essential in the ever-changing financial landscape. It invests mainly in mortgage-backed securities representing partial ownership in pools of residential or commercial mortgage loans. These securities are selected under the advisement of the Fund’s portfolio managers based on their credit quality, yield, and maturity, ensuring a balanced investment portfolio.

Role of First Trust Advisors

First Trust Advisors L.P., also known as FTA, acts as the investment advisor to the Fund. As a federally registered investment advisor, FTA brings its substantial expertise to the management of the Fund. With collective assets under management amounting to approximately $256 billion, FTA’s experience is invaluable for investors looking for stability and growth. Their partnership with First Trust Portfolios L.P., a registered broker-dealer, allows them to offer a diversified suite of investment services including unit investment trusts and exchange-traded funds.

Risk Factors in Investing

Like all investments, the Fund is not without risks. Investors should be aware of several principal risks, including market fluctuations that might affect the value of investments held by the Fund. Each risk associated with investing in the Fund is spelled out in its annual shareholder reports and regulatory filings, guiding investors through potential pitfalls.

Market Condition Implications

Current market conditions can severely impact assets owned by the Fund. Changes in fiscal policies, international relations, and even public health crises can all contribute to an investment’s volatility. Furthermore, the debt securities that the Fund invests in are subject to issuer risk, reinvestment risk, and credit risk, among others. Understanding these risks ensures that investors can gauge their own risk tolerance effectively, allowing for informed investment decisions.

Future Performance Insights

While historical performance offers some guidance, it does not guarantee future results. The investment return and overall market value will fluctuate over time. Therefore, it is essential for investors to monitor their investments closely. The anticipated distribution of $0.075 serves as a reminder of the Fund’s commitment to providing returns, while simultaneously alerting investors to the fluid nature of market investments.

Underlining Investment Considerations

Investors in the Fund must also consider the implications of short selling, futures contracts, and repurchase agreements, as these can pose additional risks if not managed properly. The complexity of various instruments used within the Fund underlines the necessity for investors to remain vigilant and informed.

Frequently Asked Questions

What is the monthly distribution amount for First Trust Mortgage Income Fund?

The Fund has declared a monthly distribution of $0.075 per share.

How is the distribution rate calculated?

The distribution rate is calculated based on the Fund's net asset value and closing market price.

What are the key risks associated with the Fund?

Risks include market risk, credit risk, and fluctuations based on current economic conditions.

Who manages the First Trust Mortgage Income Fund?

The Fund is managed by First Trust Advisors L.P., a federally registered investment advisor.

How often are distributions paid?

Distributions are typically announced and paid on a monthly basis, providing regular income to investors.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 37

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 35

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 26

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 35

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 23

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 32

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring Kotak Mahindra Bank's Innovative Tech Strategies

Updated Category News Views 587

Kotak Mahindra Bank's Commitment to Digital Transformation Kotak Mahindra Bank is at the forefront of revolutionizing financial services through its innovative technology strategies. Their latest report dives deep into the bank's extensive tech activities, highlighting how it leverages digital transformation to enhance customer experience and streamline operations....

Continue Reading
Star Group, L.P. Reflects on Fiscal 2024 Performance Updates

Updated Category News Views 349

Star Group's Fiscal 2024 Insights and Performance Analysis As the fiscal year wraps up, Star Group, L.P. (NYSE: SGU), a respected home energy distributor, shares its financial performance that ended on September 30, 2024. Amidst the prevailing challenges in the energy market, the company continues its commitment to delivering quality services while adapting to market...

Continue Reading
Krystal Biotech Launches Clinical Trial for Eye Therapy KB801

Updated Category News Views 148

Krystal Biotech Begins Phase 1/2 Trial of KB801 Krystal Biotech, Inc. (NASDAQ: KRYS) has recently announced exciting developments in its ophthalmology pipeline with the initiation of a Phase 1/2 clinical trial for KB801, aimed at treating neurotrophic keratitis (NK). This 2:1 randomized, double-masked, multicenter, placebo-controlled study, named EMERALD-1, marks a...

Continue Reading
Key Updates on the Annual General Meeting of Ignitis Group

Updated Category News Views 163

Exciting Updates for the Ignitis Group Shareholders The retained earnings figure for AB “Ignitis grup?” has been amended for the upcoming Annual General Meeting. It now stands at EUR 320,319,368.41, following a revision made only to the English version of the document. This adjustment reflects the company’s commitment to transparency and accuracy in their financial...

Continue Reading
Transforming Connectivity: The Future of mmWave Sensors Growth

Updated Category News Views 104

The mmWave sensors market was set on a blistering growth path back in 2023, valued at around USD 0.25 billion. By the time you fast-forward to 2032, projections had it skyrocketing to USD 2.40 billion, boasting a staggering CAGR of 28.59% from 2024 through 2032. You'd think this kind of momentum would have traders buzzing—oh wait, they were, especially as the push for...

Continue Reading